Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors Study completion pushed from Sep 2026 to Nov 2026 Tango Therapeutics, Inc.Phase 1/2 NCT05887492
  2. Minor: Niraparib Combination Therapies · Metastatic Castration-Resistant Prostate Cancer Study completion pushed from Dec 31, 2026 to Dec 31, 2027 Janssen Research & Development, LLCPhase 2 NCT03431350
  3. Minor: RGX-314 Gene Therapy Administered in the Suprachoroidal Space · Neovascular Age-Related Macular Degeneration (nAMD) Primary completion date changed from estimate of Aug 2026 to Oct 13, 2026 AbbViePhase 2 NCT04514653
  4. Minor: Antibiotic Treatment Strategies · Pneumonia in Outpatient Settings: (STAMPP) Trial sites expanded: 4 → 9 locations Ann & Robert H Lurie Children's Hospital of ChicagoNot applicable NCT06986148
  5. Minor: LB-LR1109, Administered Alone · Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC Study completion pushed from Mar 2028 to Dec 2028 LG ChemPhase 1 NCT06332755
  6. Minor: Ramantamig in Combination With Daratumumab With or Without Lenalidomide or of Single-agent JNJ-102299639 for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or Ramantamig in Combination With Pomalidomide for Multiple Myeloma Trial arms changed: 5 → 8 Janssen Research & Development, LLCPhase 1 NCT06768489
  7. Minor: AWT020 · Advanced Solid Tumors Start date changed from estimate of Sep 11, 2026 to Oct 15, 2026 Anwita BiosciencesPhase 1 NCT07822919
  8. Minor: Impact of a Painkiller Product on Quality-of-Life and Daily Functioning Start date pushed from Nov 2026 to Dec 2026 HALEONNot specified NCT07909590
  9. Minor: TricValve® Transcatheter Bicaval Valve System · Severe Tricuspid Regurgitation Start date pushed from Oct 2026 to Nov 2026 P+F Products + Features USA Inc.Not applicable NCT06458907
  10. Minor: Chemoradiotherapy With or Without Atezolizumab · Localized Muscle Invasive Bladder Cancer Study completion pushed from Jun 1, 2027 to Nov 13, 2027 National Cancer Institute (NCI)Phase 3 NCT03775265
  11. Minor: Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma Study completion pushed from Oct 30, 2026 to Oct 30, 2027 National Cancer Institute (NCI)Phase 2 NCT03698019
  12. Minor: Z-Endoxifen Hydrochloride · Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer Study completion pushed from Oct 30, 2026 to Oct 13, 2027 National Cancer Institute (NCI)Phase 1 NCT01327781
  13. Minor: Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial Primary completion date changed from estimate of Dec 31, 2026 to Feb 28, 2020 National Cancer Institute (NCI)Not specified NCT00339495
  14. Minor: DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery Study completion pushed from Nov 1, 2026 to Feb 1, 2027 Sivas Numune HospitalNot applicable NCT07452120
  15. Minor: Avelumab Plus Chemotherapy in the Peri-operative Treatment · Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC) Study completion pushed from Jun 15, 2026 to Jun 15, 2027 Vall d'Hebron Institute of OncologyPhase 2 NCT03979131
  16. Minor: PPF3 vs. PlaCEbo · Children and AdolescenTs With NeurOdeveloPmental DisorderS Start date pushed from Oct 2026 to Nov 2026 Holland Bloorview Kids Rehabilitation HospitalPhase 2 NCT07893964
  17. Minor: Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation Interventions modified University Hospital, Basel, SwitzerlandPhase 4 NCT07904507
  18. Minor: Nivolumab or Nivolumab/Ipilimumab · Progessive/ Recurrent Meningioma Study completion pushed from Oct 1, 2026 to Apr 1, 2027 Dana-Farber Cancer InstitutePhase 2 NCT02648997
  19. Minor: Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC) Study completion pushed from Oct 21, 2026 to Feb 3, 2027 Nantes University HospitalPhase 2 NCT07267013
  20. Minor: Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease Study completion pushed from Dec 2026 to Dec 2027 Dana-Farber Cancer InstitutePhase 1 NCT01937468
  21. Minor: Intestinal Microbiota of Patients Hospitalized With Sars-CoV-2 Study completion pushed from Jun 2026 to Jun 2027 Centre Hospitalier Universitaire de NīmesNot specified NCT05178238
  22. Minor: Artificial Intelligence Model to Predict Chronic Kidney Outcomes in a Vietnamese Cohort Final enrollment: 1959 participants (planned 1182) University Medical Center Ho Chi Minh City (UMC)Not specified NCT07751939
  23. Minor: Hyperangulated Video Laryngoscopes Used for Intubation With Simultaneous Cervical Spine Immobilization Study completion pushed from Oct 31, 2026 to Nov 30, 2026 Uniwersytet Radomski im. Kazimierza PułaskiegoNot applicable NCT07802522
  24. Minor: ERCG vs Intensive Lifestyle Intervention for Weight Regain After GLP-1 RA Discontinuation Start date pushed from Oct 5, 2026 to Nov 1, 2026 Affiliated Hospital to Academy of Military Medical SciencesNot applicable NCT07908823
  25. Minor: Contribution of Point of Care Ultrasound by the Emergency Physician to Rule Out the Small Bowel Obstruction: a Diagnostic, Multicenter Study Primary completion moved earlier from Mar 10, 2027 to Jan 2027 Nantes University HospitalNot specified NCT06803628